PatientWingPatientWing Facebook ad: “Oportunidad de estudio de ES”
Ran for 42 days, from February 4 to March 18, 2026, the last day Crush saw it.
Run by PatientWing on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Want an ad like this for your product?
Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.
Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.
About this ad
- Meta Ad Library ID
- 908828871553020
- Platforms
- Facebook, Instagram, Audience Network, Messenger and Threads
- Relaunches
- 0
- Niche
- Business & Money
Ad text
¿Alguien cercano o usted tienen esclerosis sistémica?Considere sumarse a un ensayo clínico para personas con ES. Compruebe si puedes participar sin ningún compromiso.
Where the ad sends people
tibusure.patientwing.com
Oportunidad de estudio de ES
Currently recruiting. A clinical study for people with SSc. If you have SSc, you may be eligible for the TibuSURE study, which is evaluating if a study drug may be a potential therapy for scleroderma.
Learn more: tibusure.patientwing.com(opens in a new tab)
